Experience
Pronova Biopharma Norge AS
Teva Pharmaceuticals USA, Inc.
Represented Pronova in in Hatch-Waxman patent litigation against three companies seeking to market generic versions of Lovaza®. District court found in favor of Pronova on all issues, including patent infringement, validity, and enforceability.
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc., 1:09-cv-00286, 1:10-cv-00800, D. Del., Judges Farnan, Robinson, Thynge
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc., 12-1498, -1499, Fed. Cir., Judges Dyk, O'Malley, Wallach
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.
Biogen International GmbH
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
Eli Lilly and Company
AstraZeneca Pharmaceuticals LP, Shionogi Co. v. Watson Pharmaceuticals, Inc.
AstraZeneca Pharmaceuticals LP; Shionogi Co.
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
Otsuka Pharmaceutical Co.
Eastman Chemical Co. v. AlphaPet, Inc.; DAK Americas LLC
Eastman Chemical Co.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.